Irish biotech Amarin gears up for drug launch in Europe
Company’s cardiovascular drug should be cleared in next six weeks for EU use
Company’s cardiovascular drug should be cleared in next six weeks for EU use
Nevada court rules patents are invalid in crunch battle with generic rivals
Amarin doubling size of US sales force as FDA sanctions expanded market for Vascepa
Green Reit and CRH among winners as Boeing, Denis O’Brien and RTÉ join losers
Purified fish oil drug has been recommended by FDA for wider market approval
John Thero, CEO of fish-oil drug specialist, accepts award for Irish-domiciled company
Strong increase in proft forecast on the back of sales of fish oil drug in the US
John Thero of the fish oil drug specialist recognised for company’s drug, Vascepa
Irish company’s Vascepa on track for earlier than expected approval
Stock advances over fivefold in 12 months on evidence of medicine’s cardiovascular effect
Clinical trials show Irish company’s fish-oil drug cut incidence of heart attacks and strokes
The last 12 months proved to be another year of mixed fortunes in corporate Ireland
Some concern over neutrality of placebo and whether it might have boosted Vascepa data
Company’s Vascepa drug proves effective in reducing risk from stroke and heart attack
Company targets expanded market share for fish oil drug that cuts risk of heart disease
US court rules regulator cannot bar company promoting off label use for drug
Company continues to fight regulator as it reports $166m loss in first year of commercial operation for fish oil drug
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices